McMillian
McMillian v. Sanofi S.A.
Opinion
trial_court Opinion
1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 REGINA MCMILLIAN, et al., Case No. 23-cv-05780-SI
8 Plaintiffs,
ORDER DENYING PLAINTIFF’S
9 v. MOTION FOR LEAVE TO FILE
AMENDED COMPLAINT
10 SANOFI-AVENTIS U.S LLC, Re: Dkt. No. 25 11 Defendant.
12 13 This case has been transferred to this Court from the Eastern District of Louisiana, where it 14 was part of the multi-district litigation (“MDL”) In re: Taxotere (Docetaxel) Products Liability 15 Litigation, MDL No. 2740. Plaintiff Regina McMillian now moves for leave to file an amended 16 complaint. Dkt. No. 25. Pursuant to Civil Local Rule 7-1(b), the Court finds this matter appropriate 17 for resolution without oral argument and VACATES the hearing set for March 15, 2024. For the 18 reasons set forth below, the Court DENIES plaintiff’s motion. 19 20 BACKGROUND 21 This case is one of thousands filed against various defendants regarding the drug Taxotere 22 (or Docetaxel, the generic version) and its alleged links to permanent hair…